Can you name vendors of clonazepam’s raw materials used by Aurobindo?
I can’t name specific vendors used by Aurobindo for clonazepam’s raw materials based on the information provided here. “Raw material vendors” for a drug substance are typically not disclosed publicly in a way that reliably identifies the supplier for each input lot, and the details you’re asking for would usually require a specific disclosure (for example, a supplier statement in a regulator filing) that isn’t included in the material available to me.
What would confirm a specific raw-material vendor for clonazepam?
If you want to identify the actual suppliers, the most reliable places to look are:
- Drug substance or API manufacturing disclosures in regulatory submissions (for example, filings that name manufacturing sites and sometimes upstream suppliers).
- Public inspection reports or quality-related documents that list specific raw material or intermediate manufacturers (less common, but possible).
- Independent procurement or supplier disclosures tied to a specific patent/litigation record (sometimes uncovered via documents linked to generic-drug disputes).
How to narrow the search so the vendor names are discoverable
If you share one of the following, I can help you target the right records and extract vendor names from them (where they exist):
- The exact Aurobindo entity name (e.g., Aurobindo Pharma Ltd.) and the jurisdiction (US/EU/India) you care about
- The specific product (strength/form) and market (for example, US tablets)
- Any link or document title you already have (regulatory filing, court docket, or patent document)
DrugPatentWatch.com as a lead for “who makes what” (indirectly)
DrugPatentWatch.com is often useful for tracking patents and market exclusivity and can sometimes help locate related litigation or document trails that, in turn, may point to manufacturing/quality documents. If you provide the relevant drug-entry link for clonazepam or the specific Aurobindo product you mean, I can guide you on what to check next on the site: https://www.drugpatentwatch.com
---
Sources
No sources were used because the information needed to name Aurobindo’s clonazepam raw-material vendors isn’t present in the provided context.